A prospective randomized controlled trial comparing a ureteral stent crossing versus not crossing the bladder midline
- Conditions
- reteric and renal stones
- Registration Number
- JPRN-UMIN000034067
- Lead Sponsor
- Osaka Saiseikai Izuo Hospital
- Brief Summary
Comparing changes from baseline IPSS and OABSS scores between the two groups, the crossing midline group had a worse OABSS total score than the not crossing group (3.0 +- 2.8 vs 2.0 +- 3.3, respectively; p = 0.032). There was no significant difference between the crossing vs not crossing groups in the IPSS total score (6.8 +- 7.6 vs 5.1 +- 8.5, respectively; p = 0.14).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 113
Not provided
1) Active urinary tract infection 2) Concomitant medication with alpha blockers, antimuscarinics, analgesics, beta-3 agonist, PDE 5 inhibitor 3) Pregnancy 8) Ureteral stent placement before TUL 9) Bilateral ureteral stenting 10) Bladder cancer 11) Prostate cancer 12) Neurogenic bladder 13) Chronic prostatitis 14) Complications during ureteroscopy such as ureteral perforation 15) Lower ureteral calculi
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Difference in the change in the total points of IPSS and OABSS before and after ureteral stent placement between two groups.
- Secondary Outcome Measures
Name Time Method 1. Difference in change amount of each item of IPSS 2. Difference in change amount of each item of OABSS 3. Can it be a useful indicator when choosing a ureteral stent whose height is appropriate? 4. Difference in pain due to ureteral stent during ureteral stent placement